Adam S. Elinoff joined Agilent in November 2025 as senior vice president, Agilent, and chief financial officer. In this role, he oversees all aspects of Agilent’s global finance organization, including accounting, financial planning and analysis, investor relations, treasury, and tax.
Adam brings nearly two decades of experience leading global finance, strategy and transformation initiatives in the life-sciences industry. During his 19 years at Amgen, a leading biotechnology company, he oversaw worldwide investor relations, treasury, procurement, corporate services and real-estate functions, as regional CFO he managed a multibillion-dollar P&L across 67 international markets. He also played a central role in corporate transformation and strategic planning. He established new global capability centers, advanced operational efficiency programs, and led finance teams that supported business expansion, M&A integration, and enterprise growth. His efforts contributed to improved financial performance, strengthened governance, and greater alignment between financial strategy and business priorities across Amgen’s global network.
Before that, Adam held finance-leadership roles at Shire Pharmaceuticals and International Rectifier. He began his career as a small-enterprise-development volunteer with the Peace Corps in Senegal, where he established microcredit programs for entrepreneurs in underserved regions.
Adam holds an MBA from Arizona State University and a bachelor’s degree in economics from Hamilton College.
This person is not in any teams
This person is not in any offices